DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Chao EC.
A paradigm shift in diabetes therapy -- dapagliflozin and other SGLT2 inhibitors.
Discov Med 2011; 11: 255-263
We do not assume any responsibility for the contents of the web pages of other providers.